Connect
← Return to Testosterone levels are rising after cessation of ADT
Discussion
Testosterone levels are rising after cessation of ADT
Prostate Cancer | Last Active: Sep 20, 2025 | Replies (30)Comment receiving replies
I had the same result after 13 months of Lupron. I was also on darolutamide, which I've continued alone for subsequently 18 months. I assume the darolutamide is blocking utilization of T. My PSA is < 0.1.
Replies to "I had the same result after 13 months of Lupron. I was also on darolutamide, which..."
Connect
Nubeqa (darolutamide) works in the presence of significant testosterone because it is an androgen receptor (AR) inhibitor, not a testosterone-reducing drug. It blocks testosterone's ability to stimulate prostate cancer cell growth by binding to the androgen receptor and preventing testosterone from attaching.
There are quite a few people in the Weekly ancan.org Advanced prostate cancer meetings that are only on Nubeqa. Most of them are older, and they really like the results since ADT can be difficult.